Search Results - "Saini, Massimo"
-
1
Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
Published in Cancer research (Chicago, Ill.) (15-12-2019)“…The crosstalk between cancer cells and the immune system is crucial for disease progression and its therapeutic targeting is providing exciting results, in…”
Get full text
Journal Article -
2
A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice
Published in Blood (11-07-2013)“…A productive immune response requires transient upregulation of the microRNA miR-155 in hematopoietic cells mediating innate and adaptive immunity. In order to…”
Get full text
Journal Article -
3
Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion
Published in Cell stem cell (07-12-2012)“…Lifelong blood cell production is governed through the poorly understood integration of cell-intrinsic and -extrinsic control of hematopoietic stem cell (HSC)…”
Get full text
Journal Article -
4
Single cell polarity in liquid phase facilitates tumour metastasis
Published in Nature communications (28-02-2018)“…Dynamic polarisation of tumour cells is essential for metastasis. While the role of polarisation during dedifferentiation and migration is well established,…”
Get full text
Journal Article -
5
Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway
Published in The Journal of experimental medicine (06-04-2015)“…The status of long-term quiescence and dormancy guarantees the integrity of hematopoietic stem cells (HSCs) during adult homeostasis. However the molecular…”
Get full text
Journal Article -
6
ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells
Published in Frontiers in immunology (11-07-2022)“…Breast tumors and their derived circulating cancer cells express the leukocyte β integrin ligand Intercellular adhesion molecule 1 (ICAM-1). We found that…”
Get full text
Journal Article -
7
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
Published in Oncotarget (30-09-2014)“…Although luminal-type primary breast cancer can be efficiently treated, development of metastatic disease remains a significant clinical problem. We have…”
Get full text
Journal Article -
8
To Be Taken in Count: Prostatic Tumor Cells Break Free upon Needle Biopsy
Published in Clinical chemistry (Baltimore, Md.) (01-01-2020)“…CTC counts provided by CellSearch are one of the most accurate surrogates for survival end points in prostate cancer clinical trials (7), as the hematogenous…”
Get full text
Journal Article -
9
The metastatic spread of breast cancer accelerates during sleep
Published in Nature (London) (07-07-2022)“…The metastatic spread of cancer is achieved by the haematogenous dissemination of circulating tumour cells (CTCs). Generally, however, the temporal dynamics…”
Get full text
Journal Article -
10
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Published in Nature biotechnology (01-06-2013)“…A xenograft assay facilitates identification of metastasis-initiating cells in the blood of individuals with breast cancer. It has been hypothesized that…”
Get full text
Journal Article -
11
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation
Published in Developmental cell (25-10-2021)“…Melanomas can have multiple coexisting cell states, including proliferative (PRO) versus invasive (INV) subpopulations that represent a “go or grow” trade-off;…”
Get full text
Journal Article -
12
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
Published in Nature genetics (01-03-2017)“…Saverio Minucci, Giancarlo Pruneri, Luca Magnani and colleagues identify acquired CYP19A1 amplification as a mechanism of resistance to aromatase inhibitors in…”
Get full text
Journal Article -
13
Genetic Engineering of Hematopoietic Progenitor Stem Cells for Targeted IFN-α Immunotherapy Reprogramming the Solid Tumor Microenvironment: A First-in-Man Study in Glioblastoma Multiforme (NCT03866109)
Published in Blood (02-11-2023)“…Background and methods. TEM-GBM is a Phase 1/2a dose-escalating non-randomized open label study, involving a single intravenous injection of Temferon. Temferon…”
Get full text
Journal Article -
14
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer
Published in Cell reports (Cambridge) (27-06-2023)“…The acquisition of mesenchymal traits is considered a hallmark of breast cancer progression. However, the functional relevance of epithelial-to-mesenchymal…”
Get full text
Journal Article -
15
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features
Published in Breast cancer research : BCR (25-11-2015)“…Chemotherapy resistance resulting in incomplete pathologic response is associated with high risk of metastasis and early relapse in breast cancer. The aim of…”
Get full text
Journal Article -
16
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer
Published in Breast cancer research and treatment (01-01-2019)“…Purpose Serial longitudinal enumeration of circulating tumor cells (CTCs) has shown its prognostic value on progression-free survival and overall survival (OS)…”
Get full text
Journal Article -
17
Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway
Published in The Journal of cell biology (13-04-2015)Get full text
Journal Article -
18
Abstract 652: An androgen receptor-associated transcription factor regulates fatty acid metabolism driving tumor growth in androgen receptor-positive breast cancer
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Despite advances in the treatment of breast cancer, it is still the second leading cause of cancer-related death in women worldwide. A large number of…”
Get full text
Journal Article -
19
-
20
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ER[alpha] metastatic breast cancer
Published in Nature genetics (01-06-2017)Get full text
Journal Article